|
|
Article: Reports from University of Copenhagen describe recent advances in obesity.
- Article from:
- Obesity & Diabetes Week
- Article date:
- January 5, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research from Frederiksberg, Denmark, " Weight-loss drugs produce an additional mean weight loss of only 3-5 kg above that of diet arid placebo over 6 months, and more effective pharmacotherapy of obesity is needed. We assessed the efficacy and safety of tesofensine-an inhibitor of the presynaptic uptake of noradrenaline, dopamine, and serotonin-in patients with obesity."
" We undertook a phase II, randomised, double-blind, placebo-co n trolled trial in five Danish obesity management centres. After a 2 week run-in phase, 203 obese patients (body-mass index 30-
The researchers concluded: "Funding Neurosearch A/S, Denmark."
Astrup and ...